Review of Use of Y90 as a Bridge to Liver Resection and Transplantation in Hepatocellular Carcinoma
暂无分享,去创建一个
[1] Edward Kim,et al. Radiation Segmentectomy , 2021, Seminars in Interventional Radiology.
[2] R. Salem,et al. Yttrium‐90 Radioembolization for the Treatment of Solitary, Unresectable HCC: The LEGACY Study , 2021, Hepatology.
[3] A. Kamath,et al. A comparative study of portal vein embolization versus radiation lobectomy with Yttrium-90 micropheres in preparation for liver resection for initially unresectable hepatocellular carcinoma. , 2021, Surgery.
[4] A. Jemal,et al. Cancer Statistics, 2021 , 2021, CA: a cancer journal for clinicians.
[5] R. Salem,et al. Contemporary Techniques and Applications of Radioembolization in Patients with Hepatocellular Carcinoma , 2020 .
[6] D. Ganger,et al. Liver Transplantation Following Yttrium‐90 Radioembolization: 15‐Year Experience in 207‐Patient Cohort , 2020, Hepatology.
[7] R. Salem,et al. Modified Radiation Lobectomy: An Evolving Paradigm to Convert Patients to Liver Resection Candidacy , 2019, Seminars in Interventional Radiology.
[8] C. Moulton,et al. Effect of portal vein embolization on treatment plan prior to major hepatectomy for hepatocellular carcinoma. , 2019, HPB : the official journal of the International Hepato Pancreato Biliary Association.
[9] R. Salem,et al. Neoadjuvant Radiation Lobectomy As an Alternative to Portal Vein Embolization in Hepatocellular Carcinoma. , 2019, Seminars in nuclear medicine.
[10] M. Abecassis,et al. Outcomes of Surgical Resection after Radioembolization for Hepatocellular Carcinoma. , 2018, Journal of vascular and interventional radiology : JVIR.
[11] A. Benson,et al. Institutional decision to adopt Y90 as primary treatment for hepatocellular carcinoma informed by a 1,000‐patient 15‐year experience , 2018, Hepatology.
[12] F. Miller,et al. Pictorial essay: imaging findings following Y90 radiation segmentectomy for hepatocellular carcinoma , 2018, Abdominal Radiology.
[13] M. Abecassis,et al. Radiation Segmentectomy: Potential Curative Therapy for Early Hepatocellular Carcinoma. , 2018, Radiology.
[14] M. Abecassis,et al. AASLD guidelines for the treatment of hepatocellular carcinoma , 2018, Hepatology.
[15] P. Lucatelli,et al. Trans-arterial radio-embolization: a new chance for patients with hepatocellular cancer to access liver transplantation, a world review. , 2017, Translational gastroenterology and hepatology.
[16] J. Theysohn,et al. Hepatic artery and biliary complications in liver transplant recipients with radioembolization bridging treatment for hepatocellular carcinoma , 2017, Clinical transplantation.
[17] S. Kwan,et al. Segmental Yttrium-90 Radioembolization versus Segmental Chemoembolization for Localized Hepatocellular Carcinoma: Results of a Single-Center, Retrospective, Propensity Score-Matched Study. , 2017, Journal of vascular and interventional radiology : JVIR.
[18] J. Theysohn,et al. Long-Term Outcome After Liver Transplantation for Hepatocellular Carcinoma Following Yttrium-90 Radioembolization Bridging Treatment , 2017, Annals of transplantation.
[19] M. G. Doherty,et al. Liver Resection After Selective Internal Radiation Therapy with Yttrium-90 is Safe and Feasible: A Bi-institutional Analysis , 2017, Annals of Surgical Oncology.
[20] A. Rademaker,et al. Y90 Radioembolization Significantly Prolongs Time to Progression Compared With Chemoembolization in Patients With Hepatocellular Carcinoma. , 2016, Gastroenterology.
[21] J. Bruix,et al. Evidence-Based Diagnosis, Staging, and Treatment of Patients With Hepatocellular Carcinoma. , 2016, Gastroenterology.
[22] A. Maker,et al. Hepatectomy After Yttrium-90 (Y90) Radioembolization-Induced Liver Fibrosis , 2016, Journal of Gastrointestinal Surgery.
[23] B. Goh,et al. Contra-lateral liver lobe hypertrophy after unilobar Y90 radioembolization: an alternative to portal vein embolization? , 2015, World journal of gastroenterology.
[24] M. Abecassis,et al. 90Y radiation lobectomy: Outcomes following surgical resection in patients with hepatic tumors and small future liver remnant volumes , 2015, Journal of surgical oncology.
[25] L. Henry,et al. Liver Resection for Metastatic Disease After Y90 Radioembolization: A Case Series with Long-Term Follow-Up , 2015, Annals of Surgical Oncology.
[26] M. Abecassis,et al. Unresectable solitary hepatocellular carcinoma not amenable to radiofrequency ablation: Multicenter radiology‐pathology correlation and survival of radiation segmentectomy , 2014, Hepatology.
[27] S. Kwan,et al. Superselective yttrium-90 radioembolization for hepatocellular carcinoma yields high response rates with minimal toxicity. , 2014, Journal of vascular and interventional radiology : JVIR.
[28] M. Abecassis,et al. Radiation lobectomy: time-dependent analysis of future liver remnant volume in unresectable liver cancer as a bridge to resection. , 2013, Journal of hepatology.
[29] A. Tsung,et al. Yttrium-90 radioembolization as a bridge to liver transplantation: a single-institution experience. , 2013, Journal of vascular and interventional radiology : JVIR.
[30] B. Sangro,et al. Response to radioembolization with yttrium-90 resin microspheres may allow surgical treatment with curative intent and prolonged survival in previously unresectable hepatocellular carcinoma. , 2012, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.
[31] M. Colasanti,et al. Experiences in Hepatic Surgery and Transplantation after Radioembolization , 2011 .
[32] M. Mulcahy,et al. Complications following radioembolization with yttrium-90 microspheres: a comprehensive literature review. , 2009, Journal of vascular and interventional radiology : JVIR.
[33] M. Abecassis,et al. A Comparative Analysis of Transarterial Downstaging for Hepatocellular Carcinoma: Chemoembolization Versus Radioembolization , 2009, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[34] S. Altekruse,et al. Hepatocellular carcinoma incidence, mortality, and survival trends in the United States from 1975 to 2005. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[35] V. Pamecha,et al. Effect of portal vein embolisation on the growth rate of colorectal liver metastases , 2009, British Journal of Cancer.
[36] F. Miller,et al. Biliary sequelae following radioembolization with Yttrium-90 microspheres. , 2008, Journal of vascular and interventional radiology : JVIR.
[37] N. Habib,et al. Preoperative Portal Vein Embolization for Major Liver Resection: A Meta-Analysis , 2008, Annals of surgery.
[38] T. Aikou,et al. Acceleration of primary liver tumor growth rate in embolized hepatic lobe after portal vein embolization , 2007, Acta radiologica.
[39] M. Abecassis,et al. Yttrium‐90 microspheres (TheraSphere®) treatment of unresectable hepatocellular carcinoma: Downstaging to resection, RFA and bridge to transplantation , 2006, Journal of surgical oncology.
[40] Kenneth G. Thurston,et al. Radioembolization with 90yttrium microspheres: a state-of-the-art brachytherapy treatment for primary and secondary liver malignancies. Part 2: special topics. , 2006, Journal of vascular and interventional radiology : JVIR.
[41] Kenneth G. Thurston,et al. Radioembolization with 90Yttrium microspheres: a state-of-the-art brachytherapy treatment for primary and secondary liver malignancies. Part 1: Technical and methodologic considerations. , 2006, Journal of vascular and interventional radiology : JVIR.
[42] R. Salem,et al. Successful embolization of hepatocelluar carcinoma with yttrium-90 glass microspheres prior to liver transplantation , 2006, Journal of Gastrointestinal Surgery.
[43] M. Abecassis,et al. Use of yttrium‐90 microspheres (TheraSphere®) in a patient with unresectable hepatocellular carcinoma leading to liver transplantation: A case report , 2005, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.
[44] J. Vauthey,et al. Preoperative Portal Vein Embolization for Extended Hepatectomy , 2003, Annals of surgery.
[45] V. Vilgrain,et al. Portal Vein Embolization Before Right Hepatectomy: Prospective Clinical Trial , 2003, Annals of surgery.
[46] J. Bruix,et al. Systematic review of randomized trials for unresectable hepatocellular carcinoma: Chemoembolization improves survival , 2003, Hepatology.
[47] W. Lau,et al. Preoperative Systemic Chemoimmunotherapy and Sequential Resection for Unresectable Hepatocellular Carcinoma , 2001, Annals of surgery.
[48] Y. Ikeda,et al. Preliminary report of tumor metastasis during liver regeneration after hepatic resection in rats. , 1995, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.
[49] E. Ntzani,et al. The role of portal vein embolization in the surgical management of primary hepatobiliary cancers. A systematic review. , 2017, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.
[51] R. Golfieri,et al. Yttrium-90 Radioembolization for Hepatocellular Carcinoma Prior to Liver Transplantation , 2016, World Journal of Surgery.
[52] A. Benson,et al. Radiation segmentectomy: a novel approach to increase safety and efficacy of radioembolization. , 2011, International journal of radiation oncology, biology, physics.
[53] A. Benson,et al. Radioembolization for hepatocellular carcinoma using Yttrium-90 microspheres: a comprehensive report of long-term outcomes. , 2010, Gastroenterology.
[54] J. Wong,et al. The surgical management of primary carcinoma of the liver , 2005, World Journal of Surgery.
[55] ndrea,et al. Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis. , 1996, The New England journal of medicine.
[56] D. C. Henckel,et al. Case report. , 1995, Journal.
[57] W. Ensminger,et al. Clinical pharmacology of hepatic arterial chemotherapy. , 1983, Seminars in oncology.